All Type of News
A 4-day great journey will begin for the global pharmaceutical market
At the moment where pharmaceutical companies in Korea are accelerating expansion to the global market, the 5th Korea Pharm 2015 will be opened for 4 days from 21 April at the 1st conference room of KINTEX in Goyang.
...
Korea ranked 2nd in stem cell treatment clinical trials in the world
It is known that Korea ranked the 2nd in the number of clinical trials for stem cell treatments.
National Institute of Food and Drug Safety Evaluation, the Ministry of Food and Drug Safety announced on the 7th that i...
The 7 reasons why the Act to Recover Original Medicine Cost on Defeat in Patent Dispute
In order to block the Act to Recover Original Medicine Cost on Defeat in Patent Dispute that the government is pushing forward, the Korean Research-based Pharma Industry Association (KRPIA) has devoted its energy, suc...
The less profits pharmaceutical companies make, the more sales management expenses need to be spent
It is known that mid-sized pharmaceutical companies between KRW 100 billion and KRW 200 billion sales made soundest growth last year. They actualized profits proportional to sales growth. On the other hand, large phar...
The average annual wage of internal directors of listed pharmaceutical companies is KRW 245 million
It is known that internal directors of listed pharmaceutical companies received KRW 245 million annual wages in average last year.
According to the Medipana News’s ‘2014 Current State on Annual Wages of Internal Dire...
Patient associations argue “If Xalkori is introduced in the National Health Insurance Committee…”
The Pfizer’s non-small cell lung cancer treatment ‘Xalkori (generic name: crizotinib)’ has gotten closer to application of the National Health Insurance Service. It is expected that the benefit will be provided if the...
Dongwha Pharm strengthened its psychiatric treatment field via cooperation with Pfizer
Dongwha Pharm has shown its power in the psychiatric treatment market.
Dongwha Pharm held a convention with Pfizer on the last 2nd and agreed on working as its sales agency to distribute the Pfizer Korea’s 4 products...
The Korea-China FTA rarely has short-term effects and the tariff elimination effect is also insignificant in the pharmaceutical industry
It is analyzed that impacts of the Korea-China FTA that was recently contracted are minor and the effect of the tariff elimination is insignificant.
The Ministry of Health and Welfare held a business briefing to invi...
The market capitalization of pharmaceutical stocks increased 1,786% up for the past 10 years
It is estimated that pharmaceutical stocks listed in KOSDAQ increased 1,786% up for the last 10 years.
In particular, pharmaceutical stocks listed in KOSDAQ achieved eye-opening growth compared to other industries sh...
A type B hemophiliac treatment acquired the selling approval after the launch of the Benefix 10 years ago
A competing product of the only type B hemophiliac treatment launched in Korea, Benefix, is expected to be launched.
It has been 10 years since the launch of Benefix.
On the 6th, the Ministry of Food and Drug Safety...
